Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases
Abstract This study investigated factors affecting the safety and in-stent restenosis after intracranial stent angioplasty using the Enterprise stent for symptomatic intracranial atherosclerotic stenosis. Between January 2017 and March 2019, patients with intracranial atherosclerotic stenosis treate...
Guardado en:
Autores principales: | Kun Zhang, Tian-Xiao Li, Zi-Liang Wang, Bu-Lang Gao, Jian-Jun Gu, Hui-Li Gao, Yong-Feng Wang, Jin-Chao Xia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7d9b8c77aa344bc293027c1acf160420 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis
por: Melanie Haidegger, et al.
Publicado: (2021) -
Efficacy of percutaneous transluminal renal angioplasty with stent in elderly male patients with atherosclerotic renal artery stenosis
por: Zhao J, et al.
Publicado: (2012) -
Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
por: Yong Zhu, et al.
Publicado: (2021) -
Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes
por: Grzegorz K. Jakubiak, et al.
Publicado: (2021) -
Impact of anemia on in-stent restenosis after percutaneous coronary intervention
por: Huilin Hu, et al.
Publicado: (2021)